| Hyaluronidase embedded in nanocarrier PEG shell for enhanced tumor penetration and highly efficient antitumor efficacy H Zhou, Z Fan, J Deng, PK Lemons, DC Arhontoulis, WB Bowne, ... Nano letters 16 (5), 3268-3277, 2016 | 290 | 2016 |
| Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy VG Bhoj, D Arhontoulis, G Wertheim, J Capobianchi, CA Callahan, ... Blood, The Journal of the American Society of Hematology 128 (3), 360-370, 2016 | 260 | 2016 |
| Dense and dynamic polyethylene glycol shells cloak nanoparticles from uptake by liver endothelial cells for long blood circulation H Zhou, Z Fan, PY Li, J Deng, DC Arhontoulis, CY Li, WB Bowne, ... ACS nano 12 (10), 10130-10141, 2018 | 189 | 2018 |
| Fueling cancer immunotherapy with common gamma chain cytokines CJ Dwyer, HM Knochelmann, AS Smith, MM Wyatt, GO Rangel Rivera, ... Frontiers in immunology 10, 263, 2019 | 105 | 2019 |
| Ex vivo blockade of PI3K gamma or delta signaling enhances the antitumor potency of adoptively transferred CD8+ T cells CJ Dwyer, DC Arhontoulis, GO Rangel Rivera, HM Knochelmann, ... European journal of immunology 50 (9), 1386-1399, 2020 | 62 | 2020 |
| Adoptive T cell immunotherapy for medullary thyroid carcinoma targeting GDNF family receptor alpha 4 VG Bhoj, L Li, K Parvathaneni, Z Zhang, S Kacir, D Arhontoulis, K Zhou, ... Molecular Therapy-Oncolytics 20, 387-398, 2021 | 32 | 2021 |
| Human cardiac organoids to model COVID‐19 cytokine storm induced cardiac injuries DC Arhontoulis, CM Kerr, D Richards, K Tjen, N Hyams, JA Jones, ... Journal of Tissue Engineering and Regenerative Medicine 16 (9), 799-811, 2022 | 23 | 2022 |
| Cellular and Molecular Mechanisms of MEK1 Inhibitor–Induced Cardiotoxicity TC Beck, DC Arhontoulis, JE Morningstar, N Hyams, A Stoddard, ... Cardio Oncology 4 (4), 535-548, 2022 | 13 | 2022 |
| De novo design of miniprotein antagonists of cytokine storm inducers B Huang, B Coventry, MT Borowska, DC Arhontoulis, M Exposit, M Abedi, ... Nature Communications 15 (1), 7064, 2024 | 7 | 2024 |
| GDNF family receptor alpha 4 (GFRa4)-targeted adoptive T-cell immunotherapy for medullary thyroid carcinoma VG Bhoj, S Nunez-Cruz, K Zhou, D Arhontoulis, M Feldman, K Mansfield, ... Cancer Research 76 (14_Supplement), 2295-2295, 2016 | 5 | 2016 |
| CD26 in checkpoint blockade-induced tumor immunity HM Knochelmann, D Arhontoulis, A Rivera-Reyes, M Wyatt, D Neskey, ... International Journal of Radiation Oncology, Biology, Physics 106 (5), 1132, 2020 | 2 | 2020 |
| Improving human cardiac organoid design using transcriptomics NA Hyams, CM Kerr, DC Arhontoulis, JM Ruddy, Y Mei Scientific Reports 14 (1), 20147, 2024 | | 2024 |
| Next Generation Human Cardiac Organoids: Modeling Inflammatory Diseases and Engineering Their Protection in vivo DC Arhontoulis | | 2024 |
| 575 Molecular characterization of trametinib-induced cardiotoxicity TC Beck, J Morningstar, D Arhontoulis, L Guo, G Cortney, R Biggs, ... Journal of Investigative Dermatology 142 (8), S98, 2022 | | 2022 |
| 158 Inhibition of PI3Kδ improves tumor specific T cell immunity and metabolic fitness GR Rivera, GR RIvera, C Dwyer, D Arhontoulis, H Knochelmann, A Smith, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | | 2020 |
| Tumor Microenvironment-Responsive Nanogel for Therapeutic Delivery of Interleukin-12 DC Arhontoulis Drexel University, 2016 | | 2016 |
